Assessment of Comorbidity Burden and Treatment Response: Reanalysis of the SCD-HEFT Trial

ConclusionsIncreasing comorbidity burden was associated with HTE when evaluating amiodarone and ICD compared with placebo in the SCD-HeFT trial. Our results highlight the importance of enrolling diverse patient populations in clinical trials and considering the possibility of HTE when translating results to clinical practice.

http://link.springer.com/10.1007/s40266-021-00915-w

Source: Drugs and Aging - February 1, 2022 Category: Geriatrics Source Type: research